Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2014 07:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports Second Quarter 2014 Unaudited Financial Results

MIGDAL HA'EMEQ, Israel, Aug. 5, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today reported financial...
July 31, 2014 08:00 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. to Participate in the Canaccord Genuity 34th Annual Growth Conference

MIGDAL HA'EMEQ, Israel, July 31, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today...
July 24, 2014 16:05 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. to Report Second Quarter Fiscal Year 2014 Financial Results

MIGDAL HA'EMEQ, Israel, July 24, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that it will...
July 07, 2014 08:38 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces Publication of Clinical Study Results on Crying Reduction Following Usage of INFAT(R) in Infants

MIGDAL HA'EMEQ, Israel, July 7, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today on publication...
June 23, 2014 08:47 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports Commercial Introduction of Its Innovative Omega PC(TM) Advanced Fish Oil Product

MIGDAL HA'EMEQ, Israel, June 23, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today the launch of...
June 05, 2014 16:05 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. to Present New Findings Regarding Positive Effects of INFAT(R) on Chinese Babies Stool and Behavior

MIGDAL HA'EMEQ, Israel, June 5, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that results...
May 23, 2014 08:43 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. to Participate in the Jefferies 2014 Global Healthcare Conference

MIGDAL HA'EMEQ, Israel, May 23, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today...
May 20, 2014 16:05 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Announces an Extraordinary General Meeting of Shareholders to Approve Its Compensation Policy

MIGDAL HA'EMEQ, Israel, May 20, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), today announced that it will hold an Extraordinary General Meeting of Shareholders on Thursday,...
May 15, 2014 16:05 ET | Source: Enzymotec Ltd.

Enzymotec Reports a Request for Arbitration by AAK

MIGDAL HA'EMEQ, Israel, May 15, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, reports that...
May 14, 2014 07:30 ET | Source: Enzymotec Ltd.

Enzymotec Ltd. Reports First Quarter 2014 Unaudited Financial Results

Net Revenues Increased 29% to $17.9 Million Net Income Increased 118% to $5.1 Million, or $0.22 Per Share (Quarterly Non-GAAP Net Income Increased 135% to $5.6 Million, or $0.24 Per...